Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Like many pharma stocks, Eli Lilly (NYSE ... weight loss drugs. Lilly makes tirzepatide, commercialized under the name Zepbound for weight loss and Mounjaro for type 2 diabetes.

Leerink 2025 Global Healthcare Conference March 10, 2025 9:20 AM ETCompany ParticipantsLucas Montarce - CFOMike Czapar ...

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

For kidney transplant recipients with type 2 diabetes, use of glucagon-like peptide-1 receptor agonists was associated with ...

Compounded versions of popular drugs used for weight loss including Wegovy and Zepbound will soon no longer be available ...

Novo Nordisk A/S (NYSE: NVO) has declared that its GLP-1 drugs for chronic obesity, under the brands Ozempic and Wegovy, are ...

Adults with obesity and type 2 diabetes receiving once-weekly combination cagrilintide 2.4 mg and semaglutide 2.4 mg lost ...

The two companies will work together on Zealand’s amylin analogue petrelintide as a monotherapy and in combination therapies.

President Donald Trump's nominee to lead the agency overseeing Medicare should divest financial ties to healthcare and ...